Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neuroradiology

Mapping the Network: How CPA is Diagnosed

At a Glance

Cerebral proliferative angiopathy is evaluated with MRI or CT, detailed digital subtraction angiography, and perfusion studies. Doctors look for a diffuse vessel network woven through normal brain, reduced blood flow, and little or no early vein filling—not the compact knot typically seen in an AVM.

The journey to a diagnosis of Cerebral Proliferative Angiopathy (CPA) often involves a series of advanced imaging tests. Because CPA is so rare, your doctors are looking for very specific biological “hallmarks” that separate it from more common conditions like standard Arteriovenous Malformations (AVMs) [1][2].

The Biology: A “Messy Net”

To understand your diagnostic reports, it helps to understand why CPA looks the way it does. Researchers believe CPA is driven by a cycle of ischemia (lack of oxygen) and angiogenesis (the growth of new blood vessels) [3][2].

Think of it this way: a part of your brain is “hungry” for more blood. In response, it sends out chemical signals to grow new vessels. However, instead of growing efficient “highways,” the brain grows a “messy net” of tiny, abnormal vessels [2]. Crucially, this net isn’t just sitting on top of the brain; it is woven directly into healthy, functioning brain tissue [4].

The Reference Standard: Digital Subtraction Angiography (DSA)

While an MRI or CT scan often provides the first clue, Digital Subtraction Angiography (DSA) is considered the reference standard for detailing the vascular anatomy of CPA [5][6].

During a DSA, a specialist (interventional neuroradiologist) inserts a thin tube (catheter) into an artery—usually in the groin or wrist—and moves it up to the blood vessels in the brain. They inject a special dye and take rapid X-ray images. The “subtraction” part means the computer removes the image of your skull and bones, leaving only a detailed map of your blood vessels [2].

Note that DSA is an invasive catheter procedure carrying material risks, including access-site bleeding, contrast reactions, and a small but serious risk of stroke. It requires discussion about sedation, fasting, and restrictions with your treating center.

In CPA, the DSA is essential because it can see the tiny, multiple “feeder” vessels that other scans might miss [7]. It also helps doctors check for transdural supply—blood vessels from the scalp or the brain’s lining (the dura) that have grown into the brain to help provide more blood [2][7].

Measuring the Blood Flow: Perfusion Studies

Your doctors may also order perfusion imaging (using CT or MRI). These tests don’t just look at what the vessels look like; they measure how well the blood is actually moving through your brain [3][6].

  • Hypoperfusion: This is a common finding in CPA. It means the blood is moving too slowly or there isn’t enough of it reaching the brain tissue [3][8].
  • Mean Transit Time (MTT): This measures how long it takes blood to travel through a specific area. In CPA, the MTT is often “increased,” meaning the blood is sluggish [9].
  • Cerebrovascular Reserve: This test checks if your blood vessels can still “open up” (dilate) when the brain needs more blood. In CPA, this reserve is often impaired because the vessels are already working as hard as they can [3][8]. (Assessing reserve usually requires a vasodilatory challenge, such as acetazolamide, rather than just a standard baseline scan).

Features Your Team May Assess

When you receive your imaging reports, look for these key phrases. (Please note: the absence of a phrase does not mean the absence of a feature, and transdural supply or proximal stenosis are not mandatory in every patient, so do not self-diagnose from a report’s wording.)

  1. Absence of a “Compact Nidus”: A standard AVM has a “nidus” (a tight knot of vessels). CPA typically does not have this; it is “diffuse” or “ill-defined” [2][10].
  2. Intermingled Normal Brain: The report should note that healthy brain tissue is seen inside the network of abnormal vessels [2][4].
  3. No “Early Venous Filling”: In many vascular malformations, blood “shunts” (shortcuts) directly from arteries to veins. In CPA, this “shunting” or “early filling” is typically absent or very mild [7][2].
  4. Transdural Collaterals: This refers to blood “borrowed” from the scalp or dura to help the starved brain tissue [2][7].
  5. Proximal Stenosis: Some patients with CPA have “narrowing” (stenosis) in the major arteries leading into the brain [1][2].
  6. Cortical Atrophy: Because the brain tissue has been struggling for blood flow for a long time, it may appear slightly “shrunken” or “atrophied” on scans [2][10].

Common questions in this guide

How is cerebral proliferative angiopathy diagnosed?
Doctors usually combine MRI or CT findings with digital subtraction angiography and, when needed, perfusion studies. Digital subtraction angiography provides the most detailed view of the abnormal vessel network, while perfusion tests show how well blood is reaching the brain tissue.
Why is digital subtraction angiography used for CPA?
Digital subtraction angiography creates a detailed map of the brain’s blood vessels and can show small feeder vessels or blood supply from the scalp and the brain’s lining. It is an invasive catheter procedure, so your team should explain its benefits, risks, sedation plan, fasting instructions, and activity restrictions.
What imaging findings suggest CPA instead of a typical AVM?
CPA usually appears as a diffuse, ill-defined network rather than a compact knot of vessels. Normal brain tissue may be intermingled with the abnormal vessels, and direct early filling of the veins is often absent or mild.
What can perfusion imaging show in cerebral proliferative angiopathy?
Perfusion imaging can show reduced blood flow, called hypoperfusion, and a longer mean transit time, which means blood moves more slowly through an area. Testing of cerebrovascular reserve may also show that vessels cannot widen normally when the brain needs more blood.
What does transdural supply mean on a CPA report?
Transdural supply means that vessels from the scalp or the dura, the lining around the brain, are helping deliver blood to brain tissue. It can support the diagnosis, but it is not present in every person with CPA.
Can CPA be ruled out if my imaging report does not mention a typical feature?
Not necessarily. Imaging report wording may not list every feature, and findings such as transdural supply or narrowing of a major artery are not required in every case. Ask your specialist to review the actual images and the full report rather than relying on one phrase or its absence.

Get notified when new evidence is published on Cerebral proliferative angiopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    The current clinical picture of cerebral proliferative angiopathy: systematic review.

    Yamaki VN, Solla DJF, Telles JPM, et al.

    Acta neurochirurgica 2020; (162(7)):1727-1733 doi:10.1007/s00701-020-04289-7.

    PMID: 32206904
  2. 2

    Cerebral Proliferative Angiopathy: Imaging Spectrum and Diagnostic Insights.

    Rai P, Chan VEY, Lakhani DA, et al.

    AJNR. American journal of neuroradiology 2026; (47(7)):1776-1784 doi:10.3174/ajnr.A9122.

    PMID: 41326231
  3. 3

    Cerebral revascularization in cerebral proliferative angiopathy: a systematic review.

    Somji M, McEachern J, Silvaggio J

    Neurosurgical focus 2019; (46(2)):E11.

    PMID: 30717067
  4. 4

    Hemorrhagic cerebral proliferative angiopathy in two pediatric patients: case reports.

    Ochoa A, Mantese B, Requejo F

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2022; (38(4)):789-794 doi:10.1007/s00381-021-05181-0.

    PMID: 33956211
  5. 5

    Ischemic stroke revealing diffuse cerebral proliferative angiopathy-A case report.

    Mojahid A, Mahi NE, Siouri H, et al.

    Radiology case reports 2025; (20(7)):3621-3624 doi:10.1016/j.radcr.2025.04.012.

    PMID: 40469266
  6. 6

    Cerebral proliferative angiopathy: Clinical, angiographic features and literature review.

    Liu P, Lv X, Lv M, Li Y

    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2016; (22(1)):101-7 doi:10.1177/1591019915609784.

    PMID: 26472638
  7. 7

    Cerebral proliferative angiopathy depicted by four-dimensional computed tomographic angiography: A case report.

    Ito S, Kanagaki M, Yoshimoto N, et al.

    Radiology case reports 2022; (17(7)):2332-2336 doi:10.1016/j.radcr.2022.03.104.

    PMID: 35570862
  8. 8

    Progressive Cerebral Ischemia and Intracerebral Hemorrhage after Indirect Revascularization for a Patient with Cerebral Proliferative Angiopathy.

    Kimiwada T, Hayashi T, Takahashi M, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019; (28(4)):853-858 doi:10.1016/j.jstrokecerebrovasdis.2018.11.021.

    PMID: 30737070
  9. 9

    Preoperative computed tomography perfusion in pediatric moyamoya disease: a single-institution experience.

    Ravindra VM, Kralik SF, Griauzde J, et al.

    Journal of neurosurgery. Pediatrics 2020; (25(5)):484-491 doi:10.3171/2019.10.PEDS19450.

    PMID: 31978885
  10. 10

    Infratentorial hemorrhagic cerebral proliferative angiopathy: A rare presentation of a rare disease.

    Kumar S, Sharma M, Srivastava T, Sinha VD

    Asian journal of neurosurgery 2015; (10(3)):240-2 doi:10.4103/1793-5482.161185.

    PMID: 26396618

This page explains imaging used to evaluate cerebral proliferative angiopathy for informational purposes only and does not constitute medical advice. Your neuroradiology and treating teams should interpret your reports and decide which tests are appropriate for your situation.